Cargando…
Pediatric healthcare costs for patients with 22q11.2 deletion syndrome
BACKGROUND: The 22q11.2 deletion syndrome is a variably expressed disorder that can include cardiac, palate, and other physical abnormalities, immunodeficiency, and hypocalcemia. Because of the extreme variability in phenotype, there has been no available estimate of the total medical expenditure as...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234953/ https://www.ncbi.nlm.nih.gov/pubmed/29178641 http://dx.doi.org/10.1002/mgg3.310 |
_version_ | 1783370801177690112 |
---|---|
author | Benn, Peter Iyengar, Sushma Crowley, Terrence Blaine Zackai, Elaine H. Burrows, Evanette K. Moshkevich, Solomon McDonald‐McGinn, Donna M. Sullivan, Kathleen E. Demko, Zachary |
author_facet | Benn, Peter Iyengar, Sushma Crowley, Terrence Blaine Zackai, Elaine H. Burrows, Evanette K. Moshkevich, Solomon McDonald‐McGinn, Donna M. Sullivan, Kathleen E. Demko, Zachary |
author_sort | Benn, Peter |
collection | PubMed |
description | BACKGROUND: The 22q11.2 deletion syndrome is a variably expressed disorder that can include cardiac, palate, and other physical abnormalities, immunodeficiency, and hypocalcemia. Because of the extreme variability in phenotype, there has been no available estimate of the total medical expenditure associated with the average case. METHODS: We have developed a model to estimate the cost from the time of diagnosis to age 20. Costs were based on patients seen at a specialty center but also considered those components of care expected to have been provided by external healthcare facilities. Expense was based on billed medical charges extracted from the electronic medical billing system for all patients with a diagnosis of DiGeorge or velocardiofacial syndrome from 1993–2015. Expenditures included maternal prenatal care directly related to an affected pregnancy, molecular/cytogenetic diagnosis, consultations, surgery, and/or other treatment and management. Most mental health services (except inpatient), therapy related to cognitive, behavioral, speech, pharmacy, and nonmedical costs (special education, vocational, respite, lost earnings) were not included. RESULTS: Data were available for 642 patients with 50.7% diagnosed prenatally or in the first year of life. The average cost for a patient was $727,178. Costs were highest for patients ascertained prenatally ($2,599,955) or in the first year of life ($1,043,096), those with cardiac abnormalities or referred for cardiac evaluation ($751,535), and patients with low T‐cell counts ($1,382,222). CONCLUSION: This study demonstrates that there are significant medical costs associated with 22q11.2 deletion syndrome. |
format | Online Article Text |
id | pubmed-6234953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62349532018-11-20 Pediatric healthcare costs for patients with 22q11.2 deletion syndrome Benn, Peter Iyengar, Sushma Crowley, Terrence Blaine Zackai, Elaine H. Burrows, Evanette K. Moshkevich, Solomon McDonald‐McGinn, Donna M. Sullivan, Kathleen E. Demko, Zachary Mol Genet Genomic Med Original Articles BACKGROUND: The 22q11.2 deletion syndrome is a variably expressed disorder that can include cardiac, palate, and other physical abnormalities, immunodeficiency, and hypocalcemia. Because of the extreme variability in phenotype, there has been no available estimate of the total medical expenditure associated with the average case. METHODS: We have developed a model to estimate the cost from the time of diagnosis to age 20. Costs were based on patients seen at a specialty center but also considered those components of care expected to have been provided by external healthcare facilities. Expense was based on billed medical charges extracted from the electronic medical billing system for all patients with a diagnosis of DiGeorge or velocardiofacial syndrome from 1993–2015. Expenditures included maternal prenatal care directly related to an affected pregnancy, molecular/cytogenetic diagnosis, consultations, surgery, and/or other treatment and management. Most mental health services (except inpatient), therapy related to cognitive, behavioral, speech, pharmacy, and nonmedical costs (special education, vocational, respite, lost earnings) were not included. RESULTS: Data were available for 642 patients with 50.7% diagnosed prenatally or in the first year of life. The average cost for a patient was $727,178. Costs were highest for patients ascertained prenatally ($2,599,955) or in the first year of life ($1,043,096), those with cardiac abnormalities or referred for cardiac evaluation ($751,535), and patients with low T‐cell counts ($1,382,222). CONCLUSION: This study demonstrates that there are significant medical costs associated with 22q11.2 deletion syndrome. John Wiley and Sons Inc. 2017-08-12 /pmc/articles/PMC6234953/ /pubmed/29178641 http://dx.doi.org/10.1002/mgg3.310 Text en © 2017 Natera. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Benn, Peter Iyengar, Sushma Crowley, Terrence Blaine Zackai, Elaine H. Burrows, Evanette K. Moshkevich, Solomon McDonald‐McGinn, Donna M. Sullivan, Kathleen E. Demko, Zachary Pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
title | Pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
title_full | Pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
title_fullStr | Pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
title_full_unstemmed | Pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
title_short | Pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
title_sort | pediatric healthcare costs for patients with 22q11.2 deletion syndrome |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234953/ https://www.ncbi.nlm.nih.gov/pubmed/29178641 http://dx.doi.org/10.1002/mgg3.310 |
work_keys_str_mv | AT bennpeter pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT iyengarsushma pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT crowleyterrenceblaine pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT zackaielaineh pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT burrowsevanettek pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT moshkevichsolomon pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT mcdonaldmcginndonnam pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT sullivankathleene pediatrichealthcarecostsforpatientswith22q112deletionsyndrome AT demkozachary pediatrichealthcarecostsforpatientswith22q112deletionsyndrome |